Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Most K Street leaders (90%) said Democrats are in a stronger position than the GOP ahead of the 2026 midterm elections, according to our most recent Canvass survey.

K Street: Dems stronger in 2026

Most K Street leaders (90%) said Democrats are in a stronger position than the GOP ahead of the 2026 midterm elections, according to our most recent Canvass survey.

Notably, 84% of Republican respondents ranked the Democratic Party in the more favorable position heading into the campaign season.

In their midterm messaging so far, Democrats have focused heavily on health care — including the expiration of premium enhanced ACA subsidies — and affordability. Democratic leaders have also worked to offset key House GOP redistricting gains, although which party comes out with the edge heading into the November midterms remains to be seen.

Issues top of mind. More than eight out of 10 respondents said President Donald Trump’s immigration and deportation policies will be a top issue in the midterms.

More than two-thirds said Trump’s tariff and trade negotiations will have an impact, while 51% also said mid-decade redistricting outcomes would weigh on the election.

Other major events K Street predicts will have an impact in November: the Jeffrey Epstein files (35%); military actions in Venezuela and other foreign nations (24%); and the reconciliation law (23%).

Want to take part in The Canvass? Our survey, in partnership with LSG, provides anonymous monthly insights from top Capitol Hill staffers and K Street leaders on key issues facing Washington. Sign up here if you work on K Street. Click here to sign up if you’re a senior congressional staffer.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.